flu

On Friday, Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) released topline results from the Phase 3 trial of the combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The combination candidate comprises Pfizer’s mRNA-based...

Avian influenza, also known as bird flu, has public health officials on alert after it spread to an unprecedented number of cows in the U.S. this year and led to positive tests of the virus in four U.S. dairy workers so far this year. A severe variant of the H5N1 strain infected animals ranging...

The World Health Organization has confirmed the first human death from a previously unseen strain of bird flu, H5N2, in Mexico. What Happened: The WHO announced on Thursday that a man in Mexico fell victim to a new strain of bird flu, H5N2. This strain is distinct from the H5N1 strain, which has...

Moderna Inc (NASDAQ: MRNA) shares are trading lower Friday after the company announced interim Phase 1 data for its mRNA flu vaccine. Moderna said mRNA-1010 successfully boosted hemagglutination inhibition (HAI) assay geometric mean titers against all strains 29 days after vaccination for...

Novavax, Inc. (NVAX) announced positive results from the animal study of its combo vaccine for influenza and COVID-19. The positive news however did little to stem the sell-off in shares that began in late April. What Happened: Gaithersburg, Maryland-based Novavax said data from a...

Diagnostic healthcare products manufacturer Quidel Corporation (NASDAQ: QDEL)'s shares are not fully reflecting the company's growth potential and likely positive estimate revision bias, according to Raymond James.  The Analyst Raymond James analyst Nicholas Jansen upgraded shares...

The lethal H3N2 flu strain and comorbid diseases claimed at least 4,000 lives in the U.S. last week, according to the Centers for Disease Control. The illness rate now rivals that of the swine flu in 2009 and exceeds that of the last severe flu season in 2003, when a new strain emerged. “Flu...

After the CDC released its flu report for the week ending Dec. 30, Canaccord Genuity looked at which companies could benefit from the strong start to the flu season. The report showed that 5.75 percent of U.S. outpatient visits during the week were due to influenza-like illnesses. While not a...

The FluMist influenza vaccine doesn't work in protecting kids and adults against the flu, at least according to the Centers for Disease Control and Prevention (CDC). The CDC's Advisory Committee on Immunization Practices (ACIP) voted on Wednesday to recommend the popular nasal spray, also known as...